Literature DB >> 28584005

Neutrophils Slow Disease Progression in Murine Lupus via Modulation of Autoreactive Germinal Centers.

Anna K Bird1, Martin Chang2, Jennifer Barnard2, Bruce I Goldman3, Nida Meednu2, Javier Rangel-Moreno2, Jennifer H Anolik4,2.   

Abstract

Neutrophils are well characterized as mediators of peripheral tissue damage in lupus, but it remains unclear whether they influence loss of self-tolerance in the adaptive immune compartment. Lupus neutrophils produce elevated levels of factors known to fuel autoantibody production, including IL-6 and B cell survival factors, but also reactive oxygen intermediates, which can suppress lymphocyte proliferation. To assess whether neutrophils directly influence the progression of autoreactivity in secondary lymphoid organs (SLOs), we characterized the localization and cell-cell contacts of splenic neutrophils at several stages in the progression of disease in the NZB/W murine model of lupus. Neutrophils accumulate in SLO over the course of lupus progression, preferentially localizing near T lymphocytes early in disease and B cells with advanced disease. RNA sequencing reveals that the splenic neutrophil transcriptional program changes significantly over the course of disease, with neutrophil expression of anti-inflammatory mediators peaking during early-stage and midstage disease, and evidence of neutrophil activation with advanced disease. To assess whether neutrophils exert predominantly protective or deleterious effects on loss of B cell self-tolerance in vivo, we depleted neutrophils at different stages of disease. Neutrophil depletion early in lupus resulted in a striking acceleration in the onset of renal disease, SLO germinal center formation, and autoreactive plasma cell production. In contrast, neutrophil depletion with more advanced disease did not alter systemic lupus erythematosus progression. These results demonstrate a surprising temporal and context-dependent role for neutrophils in restraining autoreactive B cell activation in lupus.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28584005      PMCID: PMC5524201          DOI: 10.4049/jimmunol.1700354

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

1.  Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus.

Authors:  Kai W Bekar; Teresa Owen; Robert Dunn; Travis Ichikawa; Wensheng Wang; Roger Wang; Jennifer Barnard; Sean Brady; Sarah Nevarez; Bruce I Goldman; Marilyn Kehry; Jennifer H Anolik
Journal:  Arthritis Rheum       Date:  2010-08

2.  Blockade of B7-H1 (programmed death ligand 1) enhances humoral immunity by positively regulating the generation of T follicular helper cells.

Authors:  Emily Hams; Mark J McCarron; Sylvie Amu; Hideo Yagita; Miyuki Azuma; Lieping Chen; Padraic G Fallon
Journal:  J Immunol       Date:  2011-04-13       Impact factor: 5.422

3.  B-cell biology and related therapies in systemic lupus erythematosus.

Authors:  Sadia Ahmed; Jennifer H Anolik
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

4.  Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus.

Authors:  Eneida Villanueva; Srilakshmi Yalavarthi; Celine C Berthier; Jeffrey B Hodgin; Ritika Khandpur; Andrew M Lin; Cory J Rubin; Wenpu Zhao; Stephen H Olsen; Matthew Klinker; David Shealy; Michael F Denny; Joel Plumas; Laurence Chaperot; Matthias Kretzler; Allen T Bruce; Mariana J Kaplan
Journal:  J Immunol       Date:  2011-05-25       Impact factor: 5.422

Review 5.  B cells responses and cytokine production are regulated by their immune microenvironment.

Authors:  Monica I Vazquez; Jovani Catalan-Dibene; Albert Zlotnik
Journal:  Cytokine       Date:  2015-03-02       Impact factor: 3.861

6.  Differential effects of estrogen and prolactin on autoimmune disease in the NZB/NZW F1 mouse model of systemic lupus erythematosus.

Authors:  K B Elbourne; D Keisler; R W McMurray
Journal:  Lupus       Date:  1998       Impact factor: 2.911

7.  Neutrophils Regulate Humoral Autoimmunity by Restricting Interferon-γ Production via the Generation of Reactive Oxygen Species.

Authors:  Xinfang Huang; Jingjing Li; Stephanie Dorta-Estremera; Jeremy Di Domizio; Scott M Anthony; Stephanie S Watowich; Daniel Popkin; Zheng Liu; Philip Brohawn; Yihong Yao; Kimberly S Schluns; Lewis L Lanier; Wei Cao
Journal:  Cell Rep       Date:  2015-08-06       Impact factor: 9.423

Review 8.  Alarmins link neutrophils and dendritic cells.

Authors:  De Yang; Gonzalo de la Rosa; Poonam Tewary; Joost J Oppenheim
Journal:  Trends Immunol       Date:  2009-08-21       Impact factor: 16.687

9.  Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus.

Authors:  Arumugam Palanichamy; Jason W Bauer; Srilakshmi Yalavarthi; Nida Meednu; Jennifer Barnard; Teresa Owen; Christopher Cistrone; Anna Bird; Alfred Rabinovich; Sarah Nevarez; Jason S Knight; Russell Dedrick; Alexander Rosenberg; Chungwen Wei; Javier Rangel-Moreno; Jane Liesveld; Inaki Sanz; Emily Baechler; Mariana J Kaplan; Jennifer H Anolik
Journal:  J Immunol       Date:  2013-12-30       Impact factor: 5.422

10.  A pathogenic IFNα, BLyS and IL-17 axis in Systemic Lupus Erythematosus patients.

Authors:  Patricia López; Javier Rodríguez-Carrio; Luis Caminal-Montero; Lourdes Mozo; Ana Suárez
Journal:  Sci Rep       Date:  2016-02-05       Impact factor: 4.379

View more
  15 in total

Review 1.  Recent advances on the crosstalk between neutrophils and B or T lymphocytes.

Authors:  Sara Costa; Dalila Bevilacqua; Marco A Cassatella; Patrizia Scapini
Journal:  Immunology       Date:  2018-10-10       Impact factor: 7.397

Review 2.  Autoimmunity in 2017.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

3.  Lack of Association Between Sex Hormones, MDSCs, LDGs and pDCs in Males and Females With Systemic Lupus Erythematosus.

Authors:  Jessica M Jones; Frances Smith; Emily Littlejohn; Trine N Jorgensen
Journal:  Front Immunol       Date:  2022-06-27       Impact factor: 8.786

4.  Integrin CD11b Negatively Regulates B Cell Receptor Signaling to Shape Humoral Response during Immunization and Autoimmunity.

Authors:  Mingqian Zhou; Paul Dascani; Chuanlin Ding; Justin T Kos; David Tieri; Xiaoying Lin; Dawn Caster; David Powell; Chengping Wen; Corey T Watson; Jun Yan
Journal:  J Immunol       Date:  2021-09-01       Impact factor: 5.426

5.  A Novel Supplementation Approach to Enhance Host Response to Sublingual Vaccination.

Authors:  John C Rowe; Zayed Attia; Eunsoo Kim; Estelle Cormet-Boyaka; Prosper N Boyaka
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

Review 6.  Neutrophil trafficking to lymphoid tissues: physiological and pathological implications.

Authors:  Mathieu-Benoit Voisin; Sussan Nourshargh
Journal:  J Pathol       Date:  2019-02-04       Impact factor: 7.996

7.  S100a9 Protects Male Lupus-Prone NZBWF1 Mice From Disease Development.

Authors:  Laura M Davison; Andres A Alberto; Hardik A Dand; Emma J Keller; Madeline Patt; Ayesha Khan; Nina Dvorina; Alexandra White; Nodoka Sakurai; Lauren N Liegl; Thomas Vogl; Trine N Jorgensen
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

Review 8.  Androgen-Induced Immunosuppression.

Authors:  Melanie R Gubbels Bupp; Trine N Jorgensen
Journal:  Front Immunol       Date:  2018-04-17       Impact factor: 7.561

Review 9.  Androgen-Mediated Anti-inflammatory Cellular Processes as Therapeutic Targets in Lupus.

Authors:  Jessica M Jones; Trine N Jørgensen
Journal:  Front Immunol       Date:  2020-06-23       Impact factor: 7.561

10.  Murine lupus is neutrophil elastase-independent in the MRL.Faslpr model.

Authors:  Rachael A Gordon; Jeremy S Tilstra; Anthony Marinov; Kevin M Nickerson; Sheldon I Bastacky; Mark J Shlomchik
Journal:  PLoS One       Date:  2020-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.